PharmaVoice

APRIL 15, 2024

The biotech is developing a ‘gene-agnostic’ approach to expand the patient pool for gene therapies.

Patients 363

Patients 363

MedCity News

APRIL 15, 2024

Two CVS stores in Rhode Island have filed petitions to join the Pharmacy Guild, which is building a national pharmacy union. The locations are close to CVS Health’s headquarters in Woonsocket, Rhode Island. The post Two CVS Locations Make Moves To Join National Pharmacy Union Movement appeared first on MedCity News.

329

329

Fierce Pharma

APRIL 15, 2024

A Novartis drug with "pipeline in a pill" potential, according to one analyst group, has delivered on that promise once again. | In a phase 3 trial, treatment with Fabhalta led to a statistically significant 38.3% reduction of proteinuria (protein in the urine) in patients with IgA nephropathy, Novartis said on Monday.

Patients 254

Patients 254

MedCity News

APRIL 15, 2024

The FDA clinical hold keeps Neumora Therapeutics from catching up to the field of biopharmaceutical companies pursuing the same target for schizophrenia. But Neumora remains on track with its lead program, a different drug in late-stage clinical testing for major depressive disorder. The post Preclinical Safety Signal Prompts FDA Clinical Hold on Neumora Schizophrenia Drug appeared first on MedCity News.

Safety 304

Safety FDA Leads Biopharma 304

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

Fierce Pharma

APRIL 15, 2024

After nearly two years of legal back and forth, Pfizer and its German partner BioNTech have won a brief reprieve in their patent fight against mRNA rival Moderna. | In a docket entry dated Friday, Massachusetts federal judge Richard G. Stearns granted a stay on Moderna's COVID-19 vaccine patent infringement lawsuit against Pfizer and BioNTech. The move will give the Patent Trial and Appeal Board more time to review challenges against two of the three relevant patents in the litigation.

252

252

Fierce Pharma

APRIL 15, 2024

Boehringer Ingelheim’s 2023 was largely marked by the highly anticipated launch of its Cyltezo, the first interchangeable biosimilar to AbbVie’s Humira. | The company's late-stage pipeline focuses on oncology, cardiorespiratory diseases, mental health and cardiovascular-renal-metabolic conditions. Boehringer looks to kick off ten new phase 2 and 3 trials in the next 12-18 months, it said in its earnings release.

205

205

MedCity News

APRIL 15, 2024

Current technology can’t single-handedly solve all dental workforce issues, but there is much it can do to lighten the burden. The post How Technology Can Alleviate Dental Workforce Challenges appeared first on MedCity News.

Management 274

Management 274

Fierce Pharma

APRIL 15, 2024

Activist investor Shah Capital, which owns 6.7% of Novavax's stock, has claimed that the vaccine developer has been “historically mismanaged” as the firm tries to install new members | Activist investor Shah Capital, which owns 6.7% of Novavax's stock, has claimed that the vaccine developer has been “historically mismanaged” as the firm tries to install new members onto the biotech's board.

Sales 174

Sales 174

Infuse Medical

APRIL 15, 2024

Sales enablement is a critical aspect of any business strategy aimed at driving revenue growth and fostering customer relationships. In today’s digital age, where consumers are bombarded with information from various channels, crafting engaging content plays a pivotal role in boosting sales performance. This comprehensive guide will delve into the intricacies of sales enablement and how businesses can leverage compelling content to drive conversions and achieve their sales objectives.

Sales 130

Sales Prospecting Distribution Marketing 130

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

Fierce Pharma

APRIL 15, 2024

Marinus Pharmaceuticals’ attempt to expand the use of its seizure medicine in a new formulation has hit a pothole. | Marinus Pharmaceuticals’ attempt to expand the use of its seizure medicine in a new formulation has hit a pothole. As a result, the company is “evaluating potential cost-saving strategies,” CEO Scott Braunstein, M.D., said in a release.

Medicine 173

Medicine Pharmaceutical 173

PharmaVoice

APRIL 15, 2024

As GLP-1s expand into new disease categories, their impact could be enough to overtake leading cardiovascular drugs.

Marketing 130

Marketing Leads 130

Fierce Pharma

APRIL 15, 2024

As Genentech bolsters its hematology portfolio with new antibody drugs and bispecifics, the Roche unit has revealed a trial win that could push its recently approved T-cell engager Columvi int | The study paired Columvi, a CD20xCD3 bispecific T-cell engager, with the chemotherapy GemOx (glofitamab-gxbm) in patients who’d tried at least one prior line of therapy and did not qualify for autologous stem cell transplants.

Patients 173

Patients 173

Infuse Medical

APRIL 15, 2024

Immersive learning refers to an educational approach that fully engages learners by surrounding them with an interactive and simulated environment. Unlike traditional methods, immersive learning leverages advanced technologies to create realistic scenarios, enabling learners to experience hands-on training in a virtual or augmented environment. Software learning has evolved significantly over the years, transitioning from static textbooks and classroom lectures to dynamic online platforms and in

Training 130

Training Education Competition Marketing 130

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

PharmaTimes

APRIL 15, 2024

Affecting over 500,000 people in the UK, IBD comprises Crohn’s disease and ulcerative colitis

120

120

pharmaphorum

APRIL 15, 2024

Regeneron has formed a corporate venture capital unit with $100 million a year to invest over the next five years in “biopharmaceutical, healthcare, and health technology” start-ups.

Healthcare 119

Healthcare Healthcare 119

PharmaTimes

APRIL 15, 2024

Approximately 14% of the competition-submitted proposals were selected to receive funding

Competition 113

Competition 113

pharmaphorum

APRIL 15, 2024

Shah Capital has fired a broadside at the management team of Novavax, seeking a change in leadership at the vaccine company and the appointment of two handpicked directors to the board. In an open letter, the hedge fund accuses Novavax’s leadership of squandering its “many significant competitive advantages and sizeable market opportunity” due to “self-inflicted problems” under the current team led by chief executive John Jacobs.

Competition 111

Competition Management Marketing 111

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy

Eversana Intouch

APRIL 15, 2024

At SXSW 2024, amidst a confluence of marketing, technology, AI, and design, one word seemed to echo through every conversation, panel, and workshop: authenticity. It’s fascinating, isn’t it? The idea of being genuine, real, and true — qualities so deeply sought after in everything we do, yet so complex and rich when we pause to unpack them. Among the minds at EVERSANA INTOUCH, with leaders spanning the spectrum from Strategic Planning to Creative Direction, and from Experience Design to Customer

Healthcare 105

Healthcare Healthcare Marketing 105

pharmaphorum

APRIL 15, 2024

Roche’s CD20xCD3 bispecific antibody Columvi has improved survival when used as a second-line therapy for diffuse large B-cell lymphoma (DLBCL) in a phase 3 trial, setting up regulatory filings for earlier use of the drug in the treatment pathway.

110

110

Pharmaceutical Commerce

APRIL 15, 2024

Results of the trial suggest that early intervention for intracerebral hemorrhage using parafascicular surgery were safe.

105

105

pharmaphorum

APRIL 15, 2024

Life sciences service provider (and pharmaphorum parent company) Eversana has completed the integration of Healthware Group, the Italy-based global agency and consultancy it acquired in October. The group will now be known as Eversana Intouch Healthware and will operate as Eversana’s sixth full-service affiliate.

Consulting 105

Consulting 105

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Pharmaceutical Commerce

APRIL 15, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma Healthcare Healthcare 105

pharmaphorum

APRIL 15, 2024

Up to one in six people in eight industrialised nations could be suffering from chronic kidney disease (CKD) by 2032, with dire consequences for “patients, [the] planet, and economies,” says a new study.

Patients 104

Patients 104

European Pharmaceutical Review

APRIL 15, 2024

Positive data from MaaT Pharma’s Microbiome Ecosystem Therapy TM (MET) MaaT013 as a treatment for acute graft-versus-host disease (aGvHD), is set to be presented at the 2024 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting. Based on the long-term survival data, at 18 months MaaT013 enabled 42 percent overall survival in all patients and 58 percent in responder patients.

Pharma 98

Pharma Patients Management Leads 98

PharmaTech

APRIL 15, 2024

C3TI will promote CDER’s clinical trial innovation activities both internally and externally.

FDA 72

FDA 72

Advertiser: ZoomInfo

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

Prospecting

European Pharmaceutical Review

APRIL 15, 2024

FUJIFILM Corporation is planning to invest $1.2 billion to expand the planned FUJIFILM Diosynth Biotechnologies manufacturing facility in Holly Springs, North Carolina, US. This news follows the organisation’s announcement of a $2 billion investment in the facility in March 2021. This additional financial boost totals the investment to over $3.2 billion, FUJIFILM confirmed.

Manufacturing 98

Manufacturing Biopharma Networking Pharmaceutical 98

Clarivate

APRIL 15, 2024

Artificial intelligence (AI) is evolving rapidly with new business use cases constantly emerging. So, how do law firms and in-house counsels ensure they don’t get left behind? Our research found that IP professionals are currently grappling with what AI could mean for them, their practice and their processes. They are keen to realize benefits but are largely skeptical about AI deployment with relatively low industry adoption.

Ethics 59

Ethics Consulting Marketing Management 59

European Pharmaceutical Review

APRIL 15, 2024

Researchers investigating environmental microbial contamination found “no seasonal climatic influences were observed” in bacteria and fungi counts present in Grade D (ISO 8) Brazilian pharmaceutical cleanrooms. Samples were obtained via surface and air monitoring over a one-year period. While microbial levels were predicted to be higher during rainy periods compared to dry spells, “no statistically significant differences in bacteria and fungi counts were found between months or seasonal period

Pharmaceutical 97

Pharmaceutical Pharmaceutical products Distribution Training 97